Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
J. Matthew Singleton currently holds 20,400 shares of CUBIST PHARMACEUTICALS INC (CBST), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, J. Matthew Singleton has been a net seller of CBST stock. They have purchased $93.3K and sold $5.6M worth of shares.
J. Matthew Singleton's most recent insider trade was on Jan 2, 2026, when they sold 20,400 shares at $0.00 per share.
J. Matthew Singleton serves as Executive at CUBIST PHARMACEUTICALS INC (CBST). They have executed 43 insider transactions totaling $5.7M over their tenure at the company.
J. Matthew Singleton holds the position of Executive at CUBIST PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
J. Matthew Singleton has shown a selling trading pattern, with $93.3K in total purchases and $5.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by J. Matthew Singleton was on May 22, 2013, when they sold $1.5M worth of CBST shares. This transaction involved 27,500 shares at $55.48 per share.
J. Matthew Singleton currently owns 20,400 shares of CUBIST PHARMACEUTICALS INC (CBST), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of J. Matthew Singleton's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. J. Matthew Singleton has 43 Form 4 filings on record as an insider at CUBIST PHARMACEUTICALS INC.
Set alerts for J. Matthew Singleton and 40,000+ other insiders.